Publication & Citation Trends
Most Cited Works
Publications
12 total
Real-world treatment patterns and patient characteristics of venetoclax combination time-limited therapy for chronic lymphocytic leukemia PDF
Cited by 0
OpenAlex
Real-world zanubrutinib treatment patterns in mantle cell lymphoma (MCL) among US community oncology patients with prior Bruton tyrosine kinase inhibitor (BTKi) therapy.
Cited by 0
OpenAlex
Real-world zanubrutinib treatment patterns in CLL/SLL among a curated sample of US community oncology patients with prior acalabrutinib therapy PDF
Cited by 0
OpenAlex
Kpg-818, a novel cereblon (CRBN) modulator, in patients with hematological malignancies: Results of a Phase 1, open-label, multiple ascending dose study PDF
Cited by 0
OpenAlex
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia PDF
Cited by 1
OpenAlex
Real-world comparison of time to next treatment for patients with high-risk CLL/SLL in first line of treatment.
Cited by 0
OpenAlex
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
Cited by 3
Semantic Scholar
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy OA
Cited by 0
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(6)
Acute Myeloid Leukemia Research
(5)
Lymphoma Diagnosis and Treatment
(4)
Acute Lymphoblastic Leukemia research
(2)
CAR-T cell therapy research
(2)
Frequent Co-Authors
Affiliations
American Institute of Physics
Detroit Medical Center
UPMC Hillman Cancer Center
University of Pittsburgh Medical Center